Medical Care

Global Long-Acting Injectables Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Long-Acting Injectables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-Acting Injectables.
The Long-Acting Injectables market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Long-Acting Injectables market comprehensively. Regional market sizes, concerning products by Type, by Application, by Product and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-Acting Injectables companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Otsuka
GSK
Eli Lilly
Alkermes
Teva Pharmaceuticals
Mapi Pharma
Lupin
Amneal
Neuraxpharm
Luye Pharma
Segment by Type
Second Generation
First Generation
Segment by Product
Fluphenazine
Haloperido
Decanoate
Risperidone
Others
Segment by Marketing Channel
Hospital
Clinic
Online
Segment by Application
Schizophrenia
Bipolar Disorder
HIV
Diabete
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Product etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Long-Acting Injectables company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long-Acting Injectables Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Second Generation
1.2.3 First Generation
1.3 Market by Product
1.3.1 Global Long-Acting Injectables Market Size Growth Rate by Product: 2020 VS 2024 VS 2031
1.3.2 Fluphenazine
1.3.3 Haloperido
1.3.4 Decanoate
1.3.5 Risperidone
1.3.6 Others
1.4 Market by Marketing Channel
1.4.1 Global Long-Acting Injectables Market Size Growth Rate by Marketing Channel: 2020 VS 2024 VS 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Online
1.5 Market by Application
1.5.1 Global Long-Acting Injectables Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Schizophrenia
1.5.3 Bipolar Disorder
1.5.4 HIV
1.5.5 Diabete
1.5.6 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Long-Acting Injectables Market Perspective (2020-2031)
2.2 Global Long-Acting Injectables Growth Trends by Region
2.2.1 Global Long-Acting Injectables Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Long-Acting Injectables Historic Market Size by Region (2020-2025)
2.2.3 Long-Acting Injectables Forecasted Market Size by Region (2026-2031)
2.3 Long-Acting Injectables Market Dynamics
2.3.1 Long-Acting Injectables Industry Trends
2.3.2 Long-Acting Injectables Market Drivers
2.3.3 Long-Acting Injectables Market Challenges
2.3.4 Long-Acting Injectables Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long-Acting Injectables Players by Revenue
3.1.1 Global Top Long-Acting Injectables Players by Revenue (2020-2025)
3.1.2 Global Long-Acting Injectables Revenue Market Share by Players (2020-2025)
3.2 Global Top Long-Acting Injectables Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Long-Acting Injectables Revenue
3.4 Global Long-Acting Injectables Market Concentration Ratio
3.4.1 Global Long-Acting Injectables Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long-Acting Injectables Revenue in 2024
3.5 Global Key Players of Long-Acting Injectables Head office and Area Served
3.6 Global Key Players of Long-Acting Injectables, Product and Application
3.7 Global Key Players of Long-Acting Injectables, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Long-Acting Injectables Breakdown Data by Type
4.1 Global Long-Acting Injectables Historic Market Size by Type (2020-2025)
4.2 Global Long-Acting Injectables Forecasted Market Size by Type (2026-2031)
5 Long-Acting Injectables Breakdown Data by Application
5.1 Global Long-Acting Injectables Historic Market Size by Application (2020-2025)
5.2 Global Long-Acting Injectables Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Long-Acting Injectables Market Size (2020-2031)
6.2 North America Long-Acting Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Long-Acting Injectables Market Size by Country (2020-2025)
6.4 North America Long-Acting Injectables Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Long-Acting Injectables Market Size (2020-2031)
7.2 Europe Long-Acting Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Long-Acting Injectables Market Size by Country (2020-2025)
7.4 Europe Long-Acting Injectables Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Long-Acting Injectables Market Size (2020-2031)
8.2 Asia-Pacific Long-Acting Injectables Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Long-Acting Injectables Market Size by Region (2020-2025)
8.4 Asia-Pacific Long-Acting Injectables Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Long-Acting Injectables Market Size (2020-2031)
9.2 Latin America Long-Acting Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Long-Acting Injectables Market Size by Country (2020-2025)
9.4 Latin America Long-Acting Injectables Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long-Acting Injectables Market Size (2020-2031)
10.2 Middle East & Africa Long-Acting Injectables Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Long-Acting Injectables Market Size by Country (2020-2025)
10.4 Middle East & Africa Long-Acting Injectables Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Long-Acting Injectables Introduction
11.1.4 Johnson & Johnson Revenue in Long-Acting Injectables Business (2020-2025)
11.1.5 Johnson & Johnson Recent Development
11.2 Otsuka
11.2.1 Otsuka Company Details
11.2.2 Otsuka Business Overview
11.2.3 Otsuka Long-Acting Injectables Introduction
11.2.4 Otsuka Revenue in Long-Acting Injectables Business (2020-2025)
11.2.5 Otsuka Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Long-Acting Injectables Introduction
11.3.4 GSK Revenue in Long-Acting Injectables Business (2020-2025)
11.3.5 GSK Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Long-Acting Injectables Introduction
11.4.4 Eli Lilly Revenue in Long-Acting Injectables Business (2020-2025)
11.4.5 Eli Lilly Recent Development
11.5 Alkermes
11.5.1 Alkermes Company Details
11.5.2 Alkermes Business Overview
11.5.3 Alkermes Long-Acting Injectables Introduction
11.5.4 Alkermes Revenue in Long-Acting Injectables Business (2020-2025)
11.5.5 Alkermes Recent Development
11.6 Teva Pharmaceuticals
11.6.1 Teva Pharmaceuticals Company Details
11.6.2 Teva Pharmaceuticals Business Overview
11.6.3 Teva Pharmaceuticals Long-Acting Injectables Introduction
11.6.4 Teva Pharmaceuticals Revenue in Long-Acting Injectables Business (2020-2025)
11.6.5 Teva Pharmaceuticals Recent Development
11.7 Mapi Pharma
11.7.1 Mapi Pharma Company Details
11.7.2 Mapi Pharma Business Overview
11.7.3 Mapi Pharma Long-Acting Injectables Introduction
11.7.4 Mapi Pharma Revenue in Long-Acting Injectables Business (2020-2025)
11.7.5 Mapi Pharma Recent Development
11.8 Lupin
11.8.1 Lupin Company Details
11.8.2 Lupin Business Overview
11.8.3 Lupin Long-Acting Injectables Introduction
11.8.4 Lupin Revenue in Long-Acting Injectables Business (2020-2025)
11.8.5 Lupin Recent Development
11.9 Amneal
11.9.1 Amneal Company Details
11.9.2 Amneal Business Overview
11.9.3 Amneal Long-Acting Injectables Introduction
11.9.4 Amneal Revenue in Long-Acting Injectables Business (2020-2025)
11.9.5 Amneal Recent Development
11.10 Neuraxpharm
11.10.1 Neuraxpharm Company Details
11.10.2 Neuraxpharm Business Overview
11.10.3 Neuraxpharm Long-Acting Injectables Introduction
11.10.4 Neuraxpharm Revenue in Long-Acting Injectables Business (2020-2025)
11.10.5 Neuraxpharm Recent Development
11.11 Luye Pharma
11.11.1 Luye Pharma Company Details
11.11.2 Luye Pharma Business Overview
11.11.3 Luye Pharma Long-Acting Injectables Introduction
11.11.4 Luye Pharma Revenue in Long-Acting Injectables Business (2020-2025)
11.11.5 Luye Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Long-Acting Injectables Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Second Generation
Table 3. Key Players of First Generation
Table 4. Global Long-Acting Injectables Market Size Growth Rate by Product (US$ Million): 2020 VS 2024 VS 2031
Table 5. Key Players of Fluphenazine
Table 6. Key Players of Haloperido
Table 7. Key Players of Decanoate
Table 8. Key Players of Risperidone
Table 9. Key Players of Others
Table 10. Global Long-Acting Injectables Market Size Growth Rate by Marketing Channel (US$ Million): 2020 VS 2024 VS 2031
Table 11. Key Players of Hospital
Table 12. Key Players of Clinic
Table 13. Key Players of Online
Table 14. Global Long-Acting Injectables Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 15. Global Long-Acting Injectables Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 16. Global Long-Acting Injectables Market Size by Region (2020-2025) & (US$ Million)
Table 17. Global Long-Acting Injectables Market Share by Region (2020-2025)
Table 18. Global Long-Acting Injectables Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 19. Global Long-Acting Injectables Market Share by Region (2026-2031)
Table 20. Long-Acting Injectables Market Trends
Table 21. Long-Acting Injectables Market Drivers
Table 22. Long-Acting Injectables Market Challenges
Table 23. Long-Acting Injectables Market Restraints
Table 24. Global Long-Acting Injectables Revenue by Players (2020-2025) & (US$ Million)
Table 25. Global Long-Acting Injectables Market Share by Players (2020-2025)
Table 26. Global Top Long-Acting Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Injectables as of 2024)
Table 27. Ranking of Global Top Long-Acting Injectables Companies by Revenue (US$ Million) in 2024
Table 28. Global 5 Largest Players Market Share by Long-Acting Injectables Revenue (CR5 and HHI) & (2020-2025)
Table 29. Global Key Players of Long-Acting Injectables, Headquarters and Area Served
Table 30. Global Key Players of Long-Acting Injectables, Product and Application
Table 31. Global Key Players of Long-Acting Injectables, Date of Enter into This Industry
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Long-Acting Injectables Market Size by Type (2020-2025) & (US$ Million)
Table 34. Global Long-Acting Injectables Revenue Market Share by Type (2020-2025)
Table 35. Global Long-Acting Injectables Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 36. Global Long-Acting Injectables Revenue Market Share by Type (2026-2031)
Table 37. Global Long-Acting Injectables Market Size by Application (2020-2025) & (US$ Million)
Table 38. Global Long-Acting Injectables Revenue Market Share by Application (2020-2025)
Table 39. Global Long-Acting Injectables Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 40. Global Long-Acting Injectables Revenue Market Share by Application (2026-2031)
Table 41. North America Long-Acting Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. North America Long-Acting Injectables Market Size by Country (2020-2025) & (US$ Million)
Table 43. North America Long-Acting Injectables Market Size by Country (2026-2031) & (US$ Million)
Table 44. Europe Long-Acting Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Europe Long-Acting Injectables Market Size by Country (2020-2025) & (US$ Million)
Table 46. Europe Long-Acting Injectables Market Size by Country (2026-2031) & (US$ Million)
Table 47. Asia-Pacific Long-Acting Injectables Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 48. Asia-Pacific Long-Acting Injectables Market Size by Region (2020-2025) & (US$ Million)
Table 49. Asia-Pacific Long-Acting Injectables Market Size by Region (2026-2031) & (US$ Million)
Table 50. Latin America Long-Acting Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 51. Latin America Long-Acting Injectables Market Size by Country (2020-2025) & (US$ Million)
Table 52. Latin America Long-Acting Injectables Market Size by Country (2026-2031) & (US$ Million)
Table 53. Middle East & Africa Long-Acting Injectables Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 54. Middle East & Africa Long-Acting Injectables Market Size by Country (2020-2025) & (US$ Million)
Table 55. Middle East & Africa Long-Acting Injectables Market Size by Country (2026-2031) & (US$ Million)
Table 56. Johnson & Johnson Company Details
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Long-Acting Injectables Product
Table 59. Johnson & Johnson Revenue in Long-Acting Injectables Business (2020-2025) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. Otsuka Company Details
Table 62. Otsuka Business Overview
Table 63. Otsuka Long-Acting Injectables Product
Table 64. Otsuka Revenue in Long-Acting Injectables Business (2020-2025) & (US$ Million)
Table 65. Otsuka Recent Development
Table 66. GSK Company Details
Table 67. GSK Business Overview
Table 68. GSK Long-Acting Injectables Product
Table 69. GSK Revenue in Long-Acting Injectables Business (2020-2025) & (US$ Million)
Table 70. GSK Recent Development
Table 71. Eli Lilly Company Details
Table 72. Eli Lilly Business Overview
Table 73. Eli Lilly Long-Acting Injectables Product
Table 74. Eli Lilly Revenue in Long-Acting Injectables Business (2020-2025) & (US$ Million)
Table 75. Eli Lilly Recent Development
Table 76. Alkermes Company Details
Table 77. Alkermes Business Overview
Table 78. Alkermes Long-Acting Injectables Product
Table 79. Alkermes Revenue in Long-Acting Injectables Business (2020-2025) & (US$ Million)
Table 80. Alkermes Recent Development
Table 81. Teva Pharmaceuticals Company Details
Table 82. Teva Pharmaceuticals Business Overview
Table 83. Teva Pharmaceuticals Long-Acting Injectables Product
Table 84. Teva Pharmaceuticals Revenue in Long-Acting Injectables Business (2020-2025) & (US$ Million)
Table 85. Teva Pharmaceuticals Recent Development
Table 86. Mapi Pharma Company Details
Table 87. Mapi Pharma Business Overview
Table 88. Mapi Pharma Long-Acting Injectables Product
Table 89. Mapi Pharma Revenue in Long-Acting Injectables Business (2020-2025) & (US$ Million)
Table 90. Mapi Pharma Recent Development
Table 91. Lupin Company Details
Table 92. Lupin Business Overview
Table 93. Lupin Long-Acting Injectables Product
Table 94. Lupin Revenue in Long-Acting Injectables Business (2020-2025) & (US$ Million)
Table 95. Lupin Recent Development
Table 96. Amneal Company Details
Table 97. Amneal Business Overview
Table 98. Amneal Long-Acting Injectables Product
Table 99. Amneal Revenue in Long-Acting Injectables Business (2020-2025) & (US$ Million)
Table 100. Amneal Recent Development
Table 101. Neuraxpharm Company Details
Table 102. Neuraxpharm Business Overview
Table 103. Neuraxpharm Long-Acting Injectables Product
Table 104. Neuraxpharm Revenue in Long-Acting Injectables Business (2020-2025) & (US$ Million)
Table 105. Neuraxpharm Recent Development
Table 106. Luye Pharma Company Details
Table 107. Luye Pharma Business Overview
Table 108. Luye Pharma Long-Acting Injectables Product
Table 109. Luye Pharma Revenue in Long-Acting Injectables Business (2020-2025) & (US$ Million)
Table 110. Luye Pharma Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report


List of Figures
Figure 1. Long-Acting Injectables Picture
Figure 2. Global Long-Acting Injectables Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Long-Acting Injectables Market Share by Type: 2024 VS 2031
Figure 4. Second Generation Features
Figure 5. First Generation Features
Figure 6. Global Long-Acting Injectables Market Size Comparison by Product (2020-2031) & (US$ Million)
Figure 7. Fluphenazine Features
Figure 8. Haloperido Features
Figure 9. Decanoate Features
Figure 10. Risperidone Features
Figure 11. Others Features
Figure 12. Global Long-Acting Injectables Market Size Comparison by Marketing Channel (2020-2031) & (US$ Million)
Figure 13. Hospital Features
Figure 14. Clinic Features
Figure 15. Online Features
Figure 16. Global Long-Acting Injectables Market Size by Application (2020-2031) & (US$ Million)
Figure 17. Global Long-Acting Injectables Market Share by Application: 2024 VS 2031
Figure 18. Schizophrenia Case Studies
Figure 19. Bipolar Disorder Case Studies
Figure 20. HIV Case Studies
Figure 21. Diabete Case Studies
Figure 22. Others Case Studies
Figure 23. Long-Acting Injectables Report Years Considered
Figure 24. Global Long-Acting Injectables Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 25. Global Long-Acting Injectables Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 26. Global Long-Acting Injectables Market Share by Region: 2024 VS 2031
Figure 27. Global Long-Acting Injectables Market Share by Players in 2024
Figure 28. Global Long-Acting Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 29. The Top 10 and 5 Players Market Share by Long-Acting Injectables Revenue in 2024
Figure 30. North America Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. North America Long-Acting Injectables Market Share by Country (2020-2031)
Figure 32. United States Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Canada Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Europe Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Europe Long-Acting Injectables Market Share by Country (2020-2031)
Figure 36. Germany Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. France Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. U.K. Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Italy Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Russia Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Ireland Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Asia-Pacific Long-Acting Injectables Market Share by Region (2020-2031)
Figure 44. China Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Japan Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. South Korea Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Southeast Asia Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. India Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Australia & New Zealand Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Latin America Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Latin America Long-Acting Injectables Market Share by Country (2020-2031)
Figure 52. Mexico Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Brazil Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Middle East & Africa Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Middle East & Africa Long-Acting Injectables Market Share by Country (2020-2031)
Figure 56. Israel Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. UAE Long-Acting Injectables Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 59. Johnson & Johnson Revenue Growth Rate in Long-Acting Injectables Business (2020-2025)
Figure 60. Otsuka Revenue Growth Rate in Long-Acting Injectables Business (2020-2025)
Figure 61. GSK Revenue Growth Rate in Long-Acting Injectables Business (2020-2025)
Figure 62. Eli Lilly Revenue Growth Rate in Long-Acting Injectables Business (2020-2025)
Figure 63. Alkermes Revenue Growth Rate in Long-Acting Injectables Business (2020-2025)
Figure 64. Teva Pharmaceuticals Revenue Growth Rate in Long-Acting Injectables Business (2020-2025)
Figure 65. Mapi Pharma Revenue Growth Rate in Long-Acting Injectables Business (2020-2025)
Figure 66. Lupin Revenue Growth Rate in Long-Acting Injectables Business (2020-2025)
Figure 67. Amneal Revenue Growth Rate in Long-Acting Injectables Business (2020-2025)
Figure 68. Neuraxpharm Revenue Growth Rate in Long-Acting Injectables Business (2020-2025)
Figure 69. Luye Pharma Revenue Growth Rate in Long-Acting Injectables Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies